ARQT icon

Arcutis Biotherapeutics
ARQT

Overview Fund Activity

136 hedge funds and large institutions have $684M invested in Arcutis Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 68 increasing their positions, 28 reducing their positions, and 29 closing their positions.

Holders
136
Holders Change
-7
Holders Change %
-4.9%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
22
Increased
68
Reduced
28
Closed
29
Calls
$5.06M
Puts
$3.61M
Net Calls
+$1.46M
Net Calls Change
-$1.41M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$40.9M
2
State Street
2
State Street
Massachusetts
$49.8M
3
RCMNY
3
Rubric Capital Management (New York)
New York
$46.5M
4
CAM
4
Cormorant Asset Management
Massachusetts
$7.62M
5
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$10.5M

Top Sellers

1
APM
1
Avidity Partners Management
Texas
$0
2
Allspring Global Investments
2
Allspring Global Investments
North Carolina
$0
3
Bank of America
3
Bank of America
North Carolina
$3.87M
4
Barclays
4
Barclays
United Kingdom
$2.22M
5
MFS
5
Mirabella Financial Services
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$87.8M 9,212,786 +50,356 +0.5%
FLSM
2
Frazier Life Sciences Management
California
$82.8M 8,684,232 – –
State Street
3
State Street
Massachusetts
$49.8M 5,226,009 +1,611,228 +45%
RCMNY
4
Rubric Capital Management (New York)
New York
$46.5M 4,884,530 +1,384,530 +40%
Jennison Associates
5
Jennison Associates
New York
$40.9M 4,293,966 +2,079,476 +94%
BlackRock
6
BlackRock
New York
$40.3M 4,231,374 -366,898 -8%
PCH
7
Polar Capital Holdings
United Kingdom
$29.8M 3,127,777 -7,736 -0.2%
BCLSI
8
Bain Capital Life Sciences Investors
Massachusetts
$28.6M 3,000,000 – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$25.3M 2,650,388 +68,257 +3%
Marshall Wace
10
Marshall Wace
United Kingdom
$22.1M 2,317,541 +12,205 +0.5%
GKIM
11
GW&K Investment Management
Massachusetts
$19.7M 2,062,683 +157,961 +8%
O
12
OrbiMed
New York
$18.2M 1,914,479 – –
Franklin Resources
13
Franklin Resources
California
$15.7M 1,652,536 +59,166 +4%
Holocene Advisors
14
Holocene Advisors
New York
$13.7M 1,440,036 -629,141 -30%
PAMS
15
Pictet Asset Management (Switzerland)
Switzerland
$12.6M 1,327,029 -329,036 -20%
PBPIA
16
Pivotal bioVenture Partners Investment Advisor
California
$10.5M 1,105,309 +536,268 +94%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$8.93M 937,447 +129,080 +16%
SCM
18
Suvretta Capital Management
New York
$8.31M 872,427 +193,036 +28%
Ensign Peak Advisors
19
Ensign Peak Advisors
Utah
$7.93M 832,540 +346,300 +71%
WP
20
Woodline Partners
California
$7.7M 807,750 +112,075 +16%
CAM
21
Cormorant Asset Management
Massachusetts
$7.62M 800,000 +800,000 New
Goldman Sachs
22
Goldman Sachs
New York
$6.62M 694,321 +447,345 +181%
American Century Companies
23
American Century Companies
Missouri
$4.86M 509,879 +1,860 +0.4%
Rafferty Asset Management
24
Rafferty Asset Management
New York
$4.76M 499,922 +195,216 +64%
Morgan Stanley
25
Morgan Stanley
New York
$4.63M 485,978 +148,324 +44%
1
2 3 4 5